Return On Assets of Aspire Biopharma Holdings, Inc. from 31 Dec 2021 to 31 Dec 2025
- Taxonomy & unit
- ratio: %
- Description
- Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
- Summary
-
Aspire Biopharma Holdings, Inc. quarterly and annual Return On Assets in % history and change rate from 31 Dec 2021 to 31 Dec 2025.
- Aspire Biopharma Holdings, Inc. Return On Assets for the quarter ending 31 Dec 2025 was -1468%, a 9393% decline year-over-year.
- Aspire Biopharma Holdings, Inc. annual Return On Assets for 2025 was -1468%, a 9393% decline from 2024.
- Aspire Biopharma Holdings, Inc. annual Return On Assets for 2024 was -15%, a 415% decline from 2023.
- Aspire Biopharma Holdings, Inc. annual Return On Assets for 2023 was 4.9%, a 338% increase from 2022.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)
Aspire Biopharma Holdings, Inc. Quarterly Return On Assets (%)
| Period | Value | YoY Chg | Change % | Start Date | End Date |
|---|---|---|---|---|---|
| Q4 2025 | -1468% | -1453% | -9393% | 01 Oct 2025 | 31 Dec 2025 |
| Q3 2025 | -1492% | -1487% | -28727% | 01 Jul 2025 | 30 Sep 2025 |
| Q2 2025 | -774% | -771% | -23545% | 01 Apr 2025 | 30 Jun 2025 |
| Q1 2025 | -435% | -442% | -6548% | 01 Jan 2025 | 31 Mar 2025 |
| Q4 2024 | -15% | -20% | -415% | 01 Oct 2024 | 31 Dec 2024 |
| Q3 2024 | -5.2% | -9.4% | -222% | 01 Jul 2024 | 30 Sep 2024 |
| Q2 2024 | -3.3% | -6.7% | -194% | 01 Apr 2024 | 30 Jun 2024 |
| Q1 2024 | 6.8% | +4.6% | +221% | 01 Jan 2024 | 31 Mar 2024 |
| Q4 2023 | 4.9% | +3.8% | +338% | 01 Oct 2023 | 31 Dec 2023 |
| Q3 2023 | 4.2% | +3.8% | +754% | 01 Jul 2023 | 30 Sep 2023 |
| Q2 2023 | 3.5% | +3.5% | +61148% | 01 Apr 2023 | 30 Jun 2023 |
| Q1 2023 | 2.1% | +2.1% | 01 Jan 2023 | 31 Mar 2023 | |
| Q4 2022 | 1.1% | +9.8% | 01 Oct 2022 | 31 Dec 2022 | |
| Q3 2022 | 0.5% | 01 Jul 2022 | 30 Sep 2022 | ||
| Q2 2022 | 0.01% | 01 Apr 2022 | 30 Jun 2022 | ||
| Q1 2022 | -0.04% | 01 Jan 2022 | 31 Mar 2022 | ||
| Q4 2021 | -8.7% | 01 Oct 2021 | 31 Dec 2021 |
Aspire Biopharma Holdings, Inc. Annual Return On Assets (%)
| Period | Value | YoY Chg | Change % | Start Date | End Date |
|---|---|---|---|---|---|
| 2025 | -1468% | -1453% | -9393% | 01 Jan 2025 | 31 Dec 2025 |
| 2024 | -15% | -20% | -415% | 01 Jan 2024 | 31 Dec 2024 |
| 2023 | 4.9% | +3.8% | +338% | 01 Jan 2023 | 31 Dec 2023 |
| 2022 | 1.1% | 01 Jan 2022 | 31 Dec 2022 |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.